Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
5.94
Nov 09 • 3:59 PM ET Dollar change+0.13 Percentage change(2.24%)
Aftermarket Close
5.94
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
16.82M
Enterprise Value
18.44M
Income
-30.83M
Sales
21.82M
Book/sh
4.32
Cash/sh
3.34
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
81
IPO
Sep 12, 2014
P/E
-
Forward P/E
-
PEG
-
P/S
0.77
P/B
1.38
P/C
1.78
P/FCF
-
EV/EBITDA
-
EV/Sales
0.85
Quick Ratio
1.77
Current Ratio
2.33
Debt/Eq
0.91
LT Debt/Eq
0.85
Option/Short
No / Yes
EPS (ttm)
-16.79
EPS next Y
-1.35
EPS next Q
-0.79
EPS this Y
56.92%
EPS next Y
76.32%
EPS next 5Y
65.57%
EPS past 3/5Y
13.32% 24.32%
Sales past 3/5Y
58.72% 38.06%
EPS Y/Y TTM
55.33%
Sales Y/Y TTM
-10.68%
EPS Q/Q
41.26%
Sales Q/Q
15.71%
Insider Own
46.22%
Insider Trans
0.00%
Inst Own
1.15%
Inst Trans
0.90%
ROA
-99.81%
ROE
-225.65%
ROIC
-136.75%
Gross Margin
24.48%
Oper. Margin
-81.79%
Profit Margin
-141.28%
SMA20
0.51%
SMA50
-8.41%
SMA200
-13.78%
Trades
Shs Outstand
2.83M
Shs Float
1.52M
52W High
9.61 -38.19%
52W Low
4.14 43.48%
Volatility
5.08% 4.70%
ATR (14)
0.34
RSI (14)
46.83
Beta
0.55
Rel Volume
0.20
Avg Volume
10.87K
Volume
2,120
Perf Week
-1.98%
Perf Month
-8.47%
Perf Quarter
-21.48%
Perf Half Y
-7.19%
Perf YTD
-14.15%
Perf Year
-7.39%
Perf 3Y
-90.13%
Perf 5Y
-95.25%
Perf 10Y
-99.89%
Prev Close
5.81
Price
5.94
Change %
2.24%
Consensus
Strong Buy
Avg. Price Target
$20.00
Implied Upside
+236.7%
Analysts5incl. previous ratings
Rating Distribution4 Buy · 0 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Feb 10, 2025Initiated
LLaidlaw
Buy$10+68.4%
Apr 03, 2017Downgrade
BCS logoBBarclays
Equal Weight → Underweight$2.50 → $1.50-74.7%
Dec 16, 2016Initiated
OPY logoOOppenheimer
Outperform
Jul 15, 2016Initiated
PPiper Jaffray
Overweight$10+68.4%
May 22, 2015Upgrade
CCanaccord Genuity
Hold → Buy$11 → $17+186.2%
May 08, 2015Reiterated
BCS logoBBarclays
Equal Weight$20 → $13+118.9%
Oct 07, 2014Initiated
BCS logoBBarclays
Equal Weight$28+371.4%
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Hudson, MA.
Interim CEO and Interim Principal Financial & Accounting OfficerMr. Joshua Hexter